Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Parasight System Inc. manages a company patent portfolio in the Biotechnology & Pharmaceuticals technology area. The portfolio currently has 1 pending office action. This activity is concentrated under a lone distinct examiner and a lone distinct art unit. This suggests that the company's current patenting strategy is focused on a specific technology that falls within a single specialized area of the patent office. The Biotechnology & Pharmaceuticals focus indicates a commitment to protecting specific biological innovations.
The busiest examiner for Parasight System Inc. is LYONS, MARY M, who is handling 1 busiest examiner pending office action. This represents the entirety of the company's current pending office actions. For practitioners, this means that the prosecution outcome is highly dependent on the individual examiner's interpretation of the claims. The presence of a lone distinct art unit confirms that the company is not currently pursuing a broad range of technical classifications, which simplifies the monitoring of the portfolio's progress.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| LYONS, MARY M | 1 | 65.5% | +41.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17990137 | METHOD OF FECAL SAMPLE PREPARATION FOR AUTOMATED IMAGE ANALYSIS | LYONS, MARY M | 149d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17990137 | METHOD OF FECAL SAMPLE PREPARATION FOR AUTOMATED IMAGE ANALYSIS | LYONS, MARY M | 149d overdue |
| Art Unit | Apps |
|---|---|
| 1645 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17990137 | METHOD OF FECAL SAMPLE PREPARATION FOR AUTOMATED IMAGE ANALYSIS | LYONS, MARY M | 1645 | §103§112 | Non-Final OA | 149d overdue | Pending | Nov 18, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial